Back to search
FDAFDA · Food and drugs·Recall number D-1036-2016

Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0185-0630-01

Published June 22, 2016 · Recall initiated: May 25, 2016

Summary

FDA records drug Class III recall D-1036-2016, published June 22, 2016 and initiated May 25, 2016. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 3,048 bottles ( 304,800 tablets); Lot: Lot # FC1960; Exp.: 02/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Package Insert

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Inc
Distributor
Nationwide
Lot
Lot # FC1960; Exp.: 02/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0185-0630-01 recalled?

Yes. FDA published recall D-1036-2016 on June 22, 2016. Reported hazard: Labeling: Incorrect or Missing Package Insert

What should I do if I have this product?

Voluntary: Firm initiated · Letter